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Abstract Induced sputum and bronchoalveolar lavage (BAL) arewidely used for retrieving cells and solublematerials
for studies of airway inflammation.Centrifuged cell samples are suitable for immunochemical identification of cellular
products.The aimwas to determine the optimal fixation procedure to detect intracellular antigens in situ. In immunocy-
tochemistry, an appropriate choice of fixation method is a prerequisite for identification of cells and, consequently, for
reliabilityresults.We compared eight fixation andpermeabilizationmethods to detect intracellular antigens in cytocen-
trifuged cell samples. Four granular proteins specific to eosinophils (eosinophil cationic protein,ECP; eosinophil peroxi-
dase, EPO) and neutrophils (human neutrophil lipocalin,HNL; myeloperoxidase,MPO) were the antigens studied.We
found thatthe organic solvents often used in immunocytochemistry are unsuitable fixatives for detection of these intra-
cellular low-molecular-weightproteins.Treatmentwith crosslinking fixatives alone resulted in incomplete penetration of
antibodiesintothe cellinteriors.Bestresultswere obtainedusinga commercialreagentOrtho PermeaFix (OPF) for flow
cytometry.Withthis, fixation andpermeabilizationtakeplace simultaneously. OPF-treated cellsretainedtheir structural
characteristics, and the antibodies studiedpenetrated both cellular and granulemembranes.With OPF treatment,ECP,
EPO,HNL, andMPOwere fixedontheirplacesingranules, andtheir antigenicitywasretained. Correct identificationof
intracellular proteins is important in characterization of the respiratory inflammatory response in clinical work and re-
search.r2002 Elsevier Science Ltd.Allrights reserved
Available online athttp://www.sciencedirect.com
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Cell samples fromblood, sputum, bronchoalveolar lavage
(BAL) specimens or other body £uids can be smeared or
centrifuged on tomicroscope slides.Cells can be stained
using conventional di¡usible stains such as May^Grˇn-
wald^Giemsa (MGG). Antibodies are large, three-di-
mensional molecules. They cannot easily penetrate
intact cellmembranes unless the latter aremadeperme-
able. In immunocytochemistry, centrifuged cell samplesReceived 26 October 2001, accepted in revised form11March 2002
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Allergy,Helsinki University Central Hospital, P.O.Box160, Fin-00029
Huch,Helsinki, Finland.Fax; +358 9 47186500;
E-mail: tuula.metso@hus.¢are normally treated with acetone or an alcohol, e.g.
methanol, before incubationwith an antibody. If a cross-
linking ¢xative such as paraformaldehyde (PFA) is used in
a cell suspension, a non-ionic detergent needs to be
added to make the cell membrane permeable. PFA has
been used in combination with a mild non-ionic saponin,
for example to locate cytokines in biopsy specimens (1).
Cell-surface antigens are often used for identi¢cation
of di¡erent classes and subclasses of peripheral blood
lymphocytes in diagnosing lymphoma and leukaemia (2).
No speci¢c surfacemarkers are known for granulocytes
but several highly speci¢c intracellular (granular) anti-
gens are known for each type of cell. Several methods
for ¢xing and permeabilizing cells for £ow cytometric
studies have recently been published. Most involve PFA










Age (years) 48.8715.3 35.573.5
Sex (F/M) 9/4 3/1
Atopy (Yes)a 1 1





Data expressed asmean7SD; nd = notdone.
aDe¢ned as atopic if at least one positive result (weal
3mm) in skin-prick testto a panelof11commoninhalant
allergens (27).
bPEF; peakexpiratory £ow.Results expressed as percen-
tage of predicted value.Reference values those of Gregg
and Nunn (28).
cFEV1; forced expiratory volume in1s.Results expressed
as percentage of predicted value.Reference values by Vil-
janen (29).
IDENTIFICATIONOFINTRACELLULARMARKERS 919¢xation combinedwith permeabilizationusing a saponin,
n-octyl-beta-D-glucopyranoside (OG), or lysolecithins
(3^5).
Induced sputum and BAL are well-established meth-
ods for retrieving cells and soluble materials from lungs
for studies of airway in£ammation (6,7). Airway in£am-
mation is characterized by increased numbers of in£am-
matory cells in bronchial mucosa, in BAL £uids, and in
sputum.High numbers of eosinophils in sputum are char-
acteristic of asthmatic in£ammation. Neutrophils are
markedly involved in in£ammation causedby respiratory
infections.High numbers of neutrophils are also found in
chronic obstructive pulmonary disease,COPD.Both eo-
sinophils and neutrophils contain mediators in their in-
tracelluar granules.Thosemediators are released on cell
activation. Levels of in£ammatory mediators in local
£uids seem to re£ect airway in£ammation better than
levels in peripheral blood (8,9).
Immunocytochemical studies of sputum are few. A
common approach has been to treat cells with period-
ate-lysine-paraformaldehyde (PLP) or organic solvents
(10^13).The present study was conducted to ¢nd a reli-
ablemethod to prepare samples and detect intracellular
antigens in cells in induced sputum and BAL samples.We
compared ¢xation andpermeabilizationmethods used in
immunocytochemistry and £ow cytometry. Specimens
were centrifuged cells from induced sputum samples
and BAL £uids, obtained from patients with respiratory
disorders and fromhealthypersons.Granulocytegranule
proteins of di¡erent molecular weights (eosinophil per-
oxidase, EPO; eosinophil cationic protein, ECP; myelo-
peroxidase,MPO; human neutrophil lipocalin, HNL) and
corresponding antibodies were studied.
METHODS
Patients and healthy persons
Sputum samples were obtained from four healthy indivi-
duals and from two individuals with acute respiratory in-
fection, ¢ve with asthma, one with COPD, and onewith
prolonged cough. Fibreoptic bronchoscopy and BAL
were performed to four patients with prolonged cough.
Final diagnoses were asthma, chronic bronchitis, and
prolonged cough for no determinable reason in two pa-
tients. For de¢nition of asthma and COPD the ATS cri-
teria were used (14). Characteristics of patients and
healthy persons are summarized inTable1.
The study was approved by the Ethics Committee of
Helsinki University Central Hospital, and all subjects
gave their informed consent to participation.
Sputum induction
Sputum inhalation has been described previously (15,16).
Brie£y, each subject inhaled 5ml of a 3% NaCl solutionfrom an ultrasonic nebulizer (Omron U1, Omron, Ger-
many).The output is about 0.25ml/min and the diameter
of nebulized droplets ranges from1to 7mm, according to
the manufacturer. Peak expiratory £ow (PEF) was mea-
sured before and after induction to ensure the proce-
dure was safe. No premedication was used. Subjects
were asked to cough during and after inhalation and to
expectorate into empty containers. Collection of spu-
tum was stopped once adequate samples had been ob-
tained,15min had passed, or subject had inhaled 5ml of
saline.
Bronchoalveolar lavage
Bronchoscopy and BAL were carried out in accordance
with a standardized protocol (17). Subjects were preme-
dicated with diazepam (10mg orally) and atropine
(0.1mg/10kg intramuscularly). After local anaesthesia
with a 2% lidocaine solution, a £exible ¢breoptic
bronchoscope (Olympus BF, type IT 30; Olympus Co.,
Tokyo, Japan) was passed through the mouth into the
trachea. Two hundred millilitres of sterile normal saline
at 371C were used to wash out the right lower lobe.
BAL samples were aspirated using gentle suction, col-
lected in a syringe, and processed immediately.The ¢rst
two washes recovered were used for diagnostic pur-
poses, the third for this study.Washeswere transported
920 RESPIRATORYMEDICINEimmediately to the laboratory and processedwithin few
minutes.
Preparation of cell samples
Induced sputum
Sputum samples were treated using a method described
by Pizzichini et al. (18). Brie£y, samples were examined
under an inverted microscope, and the more viscous
parts collectedusing forceps.Viscous sampleswere solu-
bilized by diluting themwith four times their volumes of
6.5mmol/l dithiothreitol (SputolysinTM,CalbioChem, La-
Jolla, U.S.A., diluted 10-fold with distilled water). The
mixture was incubated for 15min on a roller mixer at
room temperature. An equal volume of phosphate-buf-
fered saline (PBS) was added, and incubationwas contin-
ued for another 5min.The mixture was ¢ltered using a
53-mm mesh nylon ¢lter (Nybolt PA-53/35, Seidengaze,
Germany). Sputum cells were separated by centrifuga-
tion at 800g for 10min. Cells were resuspended in PBS
and viability was measured using theTrypan Blue exclu-
sion test (Trypan Blue Stain 0.4%, GibcoBRL, Life Tech-
nologies,U.K.). It was always greater than 90%.
Bronchoalveolar lavage
Cells were separated from BAL £uid by centrifugation at
800g for 10min at room temperature.Cells pelleted by
centrifugationwere resuspended in PBS, and cell viability
was examined.
Centrifugation of sputum and BAL cell suspensions
Suspensions of native sputum and BAL cells were centri-
fuged on to Vectabond-treated (VectabondTM Reagent,




67 kDa Eosinophilgranules, m
Eosinophil cationic
protein,ECP
18^20 kDa Eosinophilgranules, m




40 kDa Neutrophil seconda
(speci¢c) granules
aAntibodies from Pharmacia ABDiagnostics,Uppsala,Swedeat 450 rpm for 6min. Slides were air-dried for at least
30min. One slide was stained using the MGG method.
Cytospin slides for immunocytochemistry were pro-
cessed immediately or wrapped and stored at 201C
for 2 weeks to several months prior to ¢xation and per-
meabilization.The e¡ects of freezing and thawing on im-
munocytochemical results were examined in relation to
four sputum and BAL cytospin slides by studying identi-
cal slides that had and had not been frozen prior to ¢xa-
tion and permeabilization.
Fixation of cytocentrifuged samples
Frozen cytospin samples were thawed out, then treated
in eight di¡erent procedures. Those were as follows: (1)
air-drying of slides (no ¢xation); (2) treatment with acet-
one for15min at room temperature; (3) treatment with
methanol for10min at room temperature; (4) treatment
with methanol overnight at 201C; (5) treatment with
PLP (containing 0.01M periodate, 0.075M lysine and 2%
PFA) (30) for 30min; (6) treatment with 10% formalde-
hyde (FA) for 10min; (7) treatment with IntraPrep
(IntraPrepTM Permeabilization Reagent, Immunotech,
France) for 30min.Thewashing solution included a sapo-
nin in all steps; and (8) treatmentwithOrtho PermeaFix
(OPF) (Ortho Diagnostic Systems Inc., U.K.) for 40min.
OPF was used undiluted, as a concentrate.
Immunocytochemical labelling
After ¢xation and/or permeabilization, all slides were in-
cubated for 15min in PBS with 0.2% bovine serum albu-
min (BSA) prior to addition of a primary antibody to one
or other of the four antigens (Table 2).The speci¢city of
the antibodies had been tested against puri¢ed granular














mixture of six clones (IgG1)
2
ry Mouse anti-humanneutrophil
lipocalin, mixture of six clones (IgG1)
10
n.
IDENTIFICATIONOFINTRACELLULARMARKERS 921con¢rmedusing BIAcore (PharmaciaUpjohn Biosensors,
Uppsala, Sweden).
Incubationwith a primary antibody was performed at
room temperature in a humid chamber for 30min. Itwas
terminated by washing with PBS containing 0.2% BSA.
The antigen^antibody complex was visualized using a
commercial alkaline phosphatase-anti^alkaline phospha-
tase (APAAP) kit (K 670,Dako,Glostrup,Denmark) and
a Fast Red substrate, in accordance with manufacturer’s
instructions. In negative controls, the primary antibody
was omitted. Sampleswere counterstainedwithMayer’s
haematoxylin (Merck, Darmstadt, Germany) for 6min.
Cells were immunolabelled and counterstained to a sin-
gle series to minimize batch-to-batch variation.
Samples were studied using a Leica DRMB
microscope. A Fuji 200 negative ¢lm was used for
photography. Identi¢cation of cell typeswasbasedoncell
morphology with the reference to corresponding MGG-
stained slides.Characteristics were gradedusing an arbi-TABLE 3. Summaryof results
Characteristic Un¢xed Acetone Methanol, room
temperature
M
Cell structure Poor Poor Poor





Penetration ++ ++ +
Leakage (di¡usion) - - -/- - - - - - - - - -
Reproducibility Poor Excellent Poor
Scalesrelating to characteristics:Characteristics of APAAP-s
(antibodies toHNLandMPO) in sputum (n= 13) and BAL (n= 4)
separate list.
Cell structure: excellent, good, acceptable, poor.Nuclear stain
munoreactivity: +++++(through cell membrane, excellent),+
tion:+++++(through cell membrane),++++(strong),+++(inte
reaction).Leakage (di¡usion):- - - - -(worst),- - - -(strong)- - -(inte
ity: excellent (all targetcells stained), poor (some targetcells sta
FIG. 1. Cellsamples stainedusing theMay^Grunwald^Giemsa (M
ni¢cation 40 ; (b) sputumfrompatientwith asthma.Originalmagtrary scale (Table 3) and assessed by two observers (LS,
TM). Characteristics included cell structure, nuclear
staining, intensity of immunoreaction, penetration of
antibody, antigen leakage, and reproducibility ofmethod.
RESULTS
Cytocentrifuged samples were processed using various
¢xation and permeabilization methods, then incubated
with various monoclonal antibodies. Immunostained
cellswerevisualized and studiedunder amicroscope.Re-
sults are summarized inTable 3 and Figs.1^3.
Cell structure, nuclear staining, and
granularity
Parameters in relation to structurewere cell size, granu-
larity and shape of polymorphic nucleus. Identi¢cation ofethanol,201C PLP 10% FA IntraPrep Permea¢x
Acceptable Good Good Excellent Excellent
+ ++ +++ ++++ +++++
++
(MPO)
+++++ ++++ +++++ +++++
+(Others)
+ +++ +++ ++++ +++++
- - - - - - - - - - - - -
Poor Excellent Excellent Excellent Excellent
tained eosinophils (antibodies to ECPand EPO) andneutrophils
samples ¢xedbyeightdi¡erentmethods.For abbreviation, see
ing: ++++(excellent),+++(good),++(acceptable),+(poor). Im-
+++(strong),+++(intermediate),++(faint),+(poor). Penetra-
rmediate),++(faint),+(poor), 0 (no visible immunoreactivity, no
rmediate),- -(some leakage),-(no visible leakage). Reproducibil-
ined).
GG)method. (a) BAL £uid frompatientwith asthma.Originalmag-
ni¢cation100.
FIG. 2. Fixativeswith organic solvents or aldehyde-based ¢xatives. (a) Un¢xed sputumcells froma patientwith asthma. Immunola-
bellingwithmonoclonal antibody to EPO.Duetothepoor structuralpreservation and faintnuclear stainingdi¡erentcelltypes cannot
be identi¢ed.The EPO positive cell (Eo) is probably an eosinophil.Note the leakage of antigen.Originalmagni¢cation 40. (b) BAL
£uid from a patient with prolonged cough.BAL cells ¢xedwithmethanol at roomtemperature and immunolabelledwithmonoclonal
antibodies to MPO.The general structure of cells is poor and cellmembranes appear damaged.Note the twoweakly MPO-positive
neutrophils (Ne).Original magni¢cation 40. (c) Sputum cells from healthy person ¢xed with acetone and immunolabelled with
monoclonal antibodies to HNL. Structure of neutrophils is badly damaged and the leakage of HNL from the neutrophils is obvious.
The leakage causes the unspeci¢c background.Nuclear staining isweak and uneven.Originalmagni¢cation 20. (d) BAL £uid from
apatientwithchronic bronchitis.BAL cells ¢xedwith acetone andimmunolabelledwithMPOantibodies.Thegeneral structure ofcells
is acceptablebutthenuclear stainingisweak.Twoneutrophils arerelatively strongly stainedafterimmunolabellingwithMPOantibody.
Unspeci¢c background is visible.Originalmagni¢cation100. (e) BAL £uid from a patient with asthma.BAL cells ¢xedwith10% FA
and immunolabelledwithmonoclonal antibody to EPO.The cell structure seemswell preserved butthe nuclear staining isweak.The
eosinophil is brightly stainedbut staining appears uneven.Themost intensive stain is seen in the peripheryof the cell.Originalmagni¢-
cation1000. (f) BAL £uid from a patient with asthma.BAL cells ¢xed with PLP and immunostained with monoclonal antibody to
EPO.The structure ofthe cells andthe intensityof immunolabellingis similar tothat shownin (e).The cellmembrane ismoreintensively
stained thanthe interior.Originalmagni¢cation100.
922 RESPIRATORYMEDICINEAPAAP-stained cells was based on cellmorphologyusing
a corresponding MGG-stained slide as a reference [Figs.
1(a) and (b)].General structure of un¢xed cells and cells
¢xed with organic agents was poor throughout [Figs.
2(a)^(d)]. Nuclear staining with Mayer’s haematoxylin
wasweak and structural preservationwas inappropriate
[Figs. 2(a)^(d)]. In contrast, when the ¢xative contained
an aldehyde as a crosslinking reagent, di¡erent leukocyte
types could easily be identi¢ed on the basis of moder-
ately well stained nuclei [Figs. 2(e) and (f)].With Intra-
Prep, results were similar [Fig. 3(a)]. Structuralpreservation and nuclear staining with Mayer’s haema-
toxylin was best with OPF, which also preserved the
granularity of the cell [Figs. 3(b)^(f)].
Antigenicity: intensity, evenness, and
reproducibility of labelling
Immunolabelling varied from weak to moderate in un-
¢xed cell samples [Fig. 2(a)]. Immunoreactivity was very
weak and cytoplasmic, or cells remained totally negative
FIG. 3. Fixatives with agents a¡ecting permeability. The best cellular preservation and the most intensive and even immuno-
staining is obtained using OPF as ¢xative.Note the intense nuclear stain, which also facilitates identi¢cation of the di¡erent cell types
[(b)^(f)]. (a) BAL £uid frompatient with prolonged cough.BAL cells ¢xedwith IntraPrep and immunostainedwithmonoclonal anti-
body toMPO.The di¡erentcelltypes canbe identi¢ed after stainingwithMayer’shaematoxylin.Nounspeci¢cbackground stainingor
leakage of the antigen is visible.Originalmagni¢cation100. (b) BAL £uid from a patient with asthma.BAL cells ¢xedwith OPF and
immunostainedwithmonoclonal antibody to EPO.Originalmagni¢cation 20. (c) Same as previous sample but with highermagni¢-
cation.Originalmagni¢cation100. (d) Sputumobtained fromahealthyperson.Sputumcells ¢xedwithOPFandimmunostainedwith
monoclonal antibody, EG2 clone to ECP. Original magni¢cation 100. (e) BAL £uid from patient with chronic bronchitis.BAL cells
¢xedwith OPFand immunostainedwithmonoclonal antibody to MPO. Originalmagni¢cation100. (f) Sputum froma patient with
COPD. Sputumcells ¢xedwith OPF and immunostainedwithmonoclonal antibodies to HNL. Originalmagni¢cation 40. Symbols:
Ne, neutrophil;Eo, eosinophil;M, macrophage;L, lymphocyte.
IDENTIFICATIONOFINTRACELLULARMARKERS 923when samples were ¢xed with organic solvents [Figs.
2(b) and (c)], except that intensity of the MPO-positive
neutrophils in acetone-¢xed samples was substantial
[Fig. 2(d)]. In contrast, immunolabelling of cells ¢xedwith
aldehydes varied from good to excellent, depending on
themethodused [Figs. 2(e) and (f)].However, immunola-
belling was uneven, with strongperipheral staining. Eosi-
nophil andneutrophilgranuleswere occasionallypositive
with all aldehyde-containing ¢xatives. In OPF-treated
samples, immunoreaction was evenly distributed
throughout the cell, irrespective of the antibody used,
indicating that antibodies had penetrated cellular and
granule membranes [Figs. 3(b)^(f)]. Granules in eosino-
phils were always visible andmarkedly positive.No anti-gen leakage ordi¡usionwas visible in cells ¢xedwithOPE
or IntraPrep. A positively stained area adjacent to cells
was occasionally observed in un¢xed cells, indicating
leakage of antigen [Fig. 2 (a)].
Inter-sample reproducibility was excellent with cells
¢xed and permeabilized using the two commercial re-
agents (OPF and IntraPrep), PLP, formaldehyde and acet-
one. Un¢xed and methanol-¢xed cells stained unevenly
within samples. Some cells were positive, others re-
mained totally negative. There was also variation be-
tween cells in samples treated with crosslinking
¢xatives but containing no agent a¡ecting permeability.
Some cells were stained throughout, others exhibited
peripheral staining as described above.
924 RESPIRATORYMEDICINENo unspeci¢c background reaction was seen in any
cell in control samples. EG2-positive eosinophils and
EG2-immunolabelled neutrophils were however seen
[Fig. 3(d)] with all ¢xatives studied.There was no di¡er-
ence in results obtained with cytospin samples frozen
prior to ¢xation-permeabilization treatment and with
those treated immediately.
DISCUSSION
Induced sputum is increasingly used to study airway in-
£ammation in various respiratory conditions. Cytospins
of induced-sputum and BAL-£uid samples are suitable
for staining of cells. To date, few immunocytochemical
studies have been conducted in relation to sputum. Jahn-
sen et al. (19) showed that cellular EG2 reactivity, both in
blood andmucosal tissue preparations, dependedmainly
on the method of sample preparation. Thus, the inter-
pretation of results based only on positive staining in im-
munocytochemistry should be made with caution. A
reliable method to ¢x and permeabilize cells in sputum
and BAL is needed for correct interpretation of immu-
nocytochemical studies. Identi¢cation of predominant
cells is prerequisite for characterization of the respira-
tory in£ammatory response in clinical work and re-
search.
Cell-surface antigens are identi¢ed using labelled anti-
bodies, with no treatment ormild treatment. If intracel-
lular antigens need to be located, cell membranes need
to be rendered permeable using a ¢xation procedure. In
our study two criteria were established to de¢ne good
¢xation: it should preserve cell structure, maintaining
the characteristic shape of the nucleus and cell granular-
ity, and it should preserve antigenicity. Fixatives used in
the present study can be placed in one or other of three
categories: (1) organic solvents that ¢x and render cell
membranes permeable simultaneously, (2) aldehyde-
based ¢xatives that do not a¡ect permeability, and (3)
¢xatives that a¡ect permeability and have been adapted
from those used in £ow cytometry.
Fixationwith organic solvents and leaving samples un-
¢xed did not meet the criteria set for acceptability of
method.Organic solvents as ¢xatives are useful in detec-
tion of surface-membrane antigens but inappropriate in
detection of intracellular antigens.Recognition of granu-
locyteswas uncertain because nuclear staining was very
weak. It has been suggested that nucleic acids are lost,
and that phospholipids are not precipitated but ex-
tracted (20).The latter would itself result inweak nucle-
ar staining.
The studyby Jahnsen et al. (19) showed that results ob-
tainedusing organic solvents were not reproducible, and
staining e¡ects were weak. Jahnsen et al. studied one
antigen (ECP) and two antibodies to di¡erent epitopes
(monoclonal antibodies EG2 and EG1).Our observationsrelate to several granulocyte markers of di¡erentmole-
cular weights and accordwith their ¢ndings. Positive sig-
nals wereweak for HNL and ECP, weak tomoderate for
EPO, andmoderate for MPO when ¢xation was carried
out using organic solvents. Staining was di¡use because
of redistribution of antigens inside cells. No positive
granules were observed, either because of antigen leak-
age resulting from incomplete ¢xation or because of
poor penetration of large antibody molecules into cells.
The possibilities of leakage and redistribution of antigens
are supported by previous ¢ndings of inadequate immo-
bilization of proteins with use of organic solvents
(19,21,22). Melan et al. (23) have suggested that antigens
with molecular weights below 100kDa are extracted if
cells are ¢xedwith organic solvents at low temperatures.
Our results suggest that cells with small proteins tend to
exhibit greatest losses of antigenicity. The molecular
weight of ECP is 18^20kDa, of HNL 40kDa, of EPO
67kDa, and of MPO over118kDa. It is therefore not sur-
prising that these antigens generally were not properly
revealed and cells were only weakly positive in samples
¢xed with organic solvents at any temperature.The lar-
gest antigen MPO (molecular weight exceeding100kDa)
exhibited greatest immunoreactivity when ¢xation was
carried out using acetone at room temperature or using
coldmethanol. Jahnsen et al. (19) have suggested that the
variable and weak staining observed is a consequence of
insu⁄cient ¢xation and, consequently, leaching of anti-
gen.Our results support this suggestion.
Aldehyde-based ¢xatives (e.g. formalin) does not ¢x
by coagulation but crosslink proteins through reaction
with basic amino acids, and formation of chemically
stable methylene bridges (24). Structural preservation is
good but steric hindrance often occurs, making use of
formalin unsuitable in relation to many antigens. Two
crosslinking ¢xatives^ formaldehyde (as formalin) and
PLP with PFA^were used in the study reportedhere re-
lating to detection of intracellular antigens.Results for all
antibodies tested were similar with both of these ¢xa-
tives.Cell preservationwas acceptable andnuclear stain-
ing was better with these ¢xatives than when organic
solvents were used for ¢xing. Immunoreactivity was
moderate. In a study by Jahnsen et al. (19), similar results
were obtained with EG2 antibody. They also noticed
poor penetration in formaldehyde-treated cell samples.
We often observed peripheral staining, indicating that
antibodies hadnotpassedproperly into cells. Reproduci-
bility from sample to samplewas excellent.
Two commercial reagents (IntraPrep,OPF) marketed
for ¢xation and permeabilization of cells in suspension in
£ow cytometry were studied. As far as we know, this
was the ¢rst time they havebeenused in relation to spu-
tum-sample and BAL-£uid cells. Modi¢cations to the
procedures were necessary since visualization in immu-
nocytochemistry involves complicated multistep proce-
dures, not direct labelling as in £ow cytometry.
IDENTIFICATIONOFINTRACELLULARMARKERS 925According to information provided by the manufac-
turers, bothproducts contain formaldehyde (as formalin)
as ¢xative, IntraPrep at a concentration of 5.5%, andOPF
at a concentration of 1.78%. Permeabilization is achieved
using a saponin in IntraPrep, a detergent and dimethyl-
sulphoxide (DMSO) in OPF (25). DMSO is known to in-
teract non-speci¢cally with phospholipid membranes,
resulting in membrane stabilization and leading to de-
creased £uidity and increasedmicroviscosity andperme-
ability of cellmembranes (26). An important property of
OPF is its ability to ¢x and permeabilize cells in a single
step for intracellular antigen detection.OPF also allows
access to numerous intracellular compartments, includ-
ing the nucleus, cytoplasmic organelles such as mito-
chondria and cytoplasmic granules in addition to
cytoplasmic proteins (25).The same treatment protocol
was used for all antigens and antibodies, without optimi-
zation for each.When cells were treated with OPF, we
observed better penetration and immunoreactivity, and
results were more reproducible than with IntraPrep,
which did not allow complete penetration of eosinophil
granules.
BAL and sputum cell sampleswere treated slightly dif-
ferently prior to ¢xation, but according to established
methods. Sputum samples were treated with a reducing
reagent, dithiothreitol (DTT), while BAL £uid samples
were not. DTT could in principle interfere with detec-
tion of marker proteins containing disulphide bonds but
this could not happen in the present study because we
investigated cytoplasmic markers from cells that were
viable after DTT treatment.
In conclusion, this study demonstrated that organic
solvents are not suitable for use as ¢xatives in detecting
the intracellular proteins ECP, EPO, and HNL. Crosslink-
ing ¢xatives necessitate permeabilization of cell mem-
branes if intracellular antigens are to be identi¢ed using
labelled antibodies. Best results in reletion to cells in in-
duced sputum and BAL samples were achieved using
Ortho PermeaFix (OPF), a reagent marketed for the
¢xation and permeabilization of cells in suspension in
£ow cytometry. OPF best met the criteria for a good
method of location of intracellular antigens. Fixation
and permeabilization procedures using reagents in-
tended for use in £ow cytometry seem to allow investi-
gation of intracellular markers in cytospin preparations
of induced sputum and BAL samples.
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